Molecular Sensing
Latest round
- Series B
Last raised
- Jul 2014
Total raised
- $1.9M
Investors
- 3
About Molecular Sensing
, is commercializing molecular interaction assay system based on Back-Scattering Interferometry (BSI). The company provides technology for biophysical characterization of small molecule interactions with complex drug targets.
Who invested in Molecular Sensing
3 investors across 1 round
See all investors in Molecular Sensing
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jul 21, 2014
Amount
$1.9M
Investors
Questions about Molecular Sensing
Who invested in Molecular Sensing?
Molecular Sensing has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Molecular Sensing raised?
Molecular Sensing has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Molecular Sensing last raise money?
Molecular Sensing's most recent round on record is a Series B, in Jul 2014.
What does Molecular Sensing do?
, is commercializing molecular interaction assay system based on Back-Scattering Interferometry (BSI).
Where is Molecular Sensing headquartered?
Molecular Sensing is headquartered in Nashville, US.
Which VCs invest in companies like Molecular Sensing?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Molecular Sensing's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Molecular Sensing? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.